Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Suayip, Yalcin"'
Autor:
Hakan Akbulut, Ahmet Taner Sümbül, Gulnihal Tufan, Özlem Sönmez, Ahmet Özet, Suayip Yalcin, Aziz Karaoğlu, Ebru Çilbir, Fatih Yildiz, Mehmet Ali Nahit Sendur, Omer Dizdar, Nazim Serdar Turhal, Nuri Karadurmus, Serhat Ünal
Publikováno v:
Journal of Oncological Sciences. 7:1-6
Autor:
Mehmet Ali Nahit Sendur, Ahmet Taner Sümbül, Özlem Sönmez, Fatih Yildiz, Suayip Yalcin, Omer Dizdar, Ahmet Özet, Hakan Akbulut, Nazim Serdar Turhal, Gulnihal Tufan, Nuri Karadurmus, Serhat Ünal, Aziz Karaoglu, Ebru Çilbir
Publikováno v:
Journal of Oncological Sciences. 6:1-4
Autor:
Deniz Can Guven, Mustafa Erman, Onur Mr, Erdemir Ag, Oktay Halit Aktepe, Suayip Yalcin, Gurkan Guner
Background: To explore the clinical significance of baseline volumetric body composition parameters evaluated with computerized tomography (CT) and their changes after 3-4 months from treatment initiation of targeted therapy in patients with metastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73a35cb942bfba2bbf4b61ae3761d617
https://doi.org/10.22541/au.161987971.18594998/v1
https://doi.org/10.22541/au.161987971.18594998/v1
Autor:
Neslihan Duzkale, Tugba Taskin Turkmenoglu, Tulay Eren, Suayip Yalcin, Ozlem Oz, Kadir Cetinkaya
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 30(7)
Objective To investigate the genetic causes of colorectal cancers (CRCs); and to determine the genotype-phenotype correlation. Study design Descriptive study. Place and duration of study Department of Medical Genetics, Diskapi Yildirim Beyazit Traini
Autor:
Hasan Cagri Yildirim, Taha Koray Sahin, Oktay Halit Aktepe, Deniz Can Guven, Omer Dizdar, Serkan Akin, Hakan Taban, Sercan Aksoy, Suayip Yalcin, Ibrahim Yahya Cakir, Emre Bilgin, Mustafa Erman, Sadettin Kilickap
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(8)
Although the immune checkpoint inhibitors (ICIs) became a vital part of cancer care, many patients do not respond to treatment, indicating need for biomarkers. The Pan-Immune-Inflammation Value (PIV) is a recently developed peripheral blood count-bas
Autor:
Alev Turker, Neyran Kertmen, Deniz Can Guven, Melek Seren Aksun, Sadettin Kilickap, Omer Dizdar, Fatih M. Uckun, Enes Ucgul, Burak Yasin Aktas, Gurkan Guner, Hasan Cagri Yildirim, Taha Koray Sahin, Suayip Yalcin, Sercan Aksoy, Zafer Arik
Publikováno v:
Annals of Oncology
Background: Prioritizing the continuum of care for cancer patients while maximizing patient safety is of paramount importance However, COVID-19 pandemic could create a collateral damage in all domains of cancer care Here, we evaluate the early change
Autor:
Deniz Can Guven, Burcu Celikten, Sadettin Kilickap, Omer Dizdar, Hakan Taban, Aytekin Akyol, S.C. Efil, Suayip Yalcin, E. Çelebiyev, Gurkan Guner
Publikováno v:
Annals of Oncology. 32:S561
Autor:
Hakan Taban, Erhan Hamaloglu, Sadettin Kilickap, Deniz Can Guven, Oktay Halit Aktepe, Suayip Yalcin, Furkan Ceylan, Aynur Isik, Aytekin Akyol, Derya Karakoc, Alev Turker, Omer Dizdar
Publikováno v:
Annals of Oncology. 31:S947
Autor:
Omer Dizdar, Hakan Taban, Burak Yasin Aktas, Sadettin Kilickap, Deniz Can Guven, Mustafa Erman, Suayip Yalcin, R.F. Degirmenciler, Sercan Aksoy, Neyran Kertmen, Zafer Arik, Alev Turker, Oktay Halit Aktepe
Publikováno v:
Annals of Oncology
Background: In the new era the COVID-19 disease became a world-wide pandemic in a short time, medical practice is predicted to be affected due to the both physician and patient tendencies, and usage of limited diagnosis and treatment opportunities fo
Autor:
Fani Bozkurt, Bora Peynircioglu, Ferhun Balkanci, Gamze Turk, Barbaros Cil, Saadettin Kilickap, Bilge Volkan Salanci, Suayip Yalcin, Gonca Eldem
Publikováno v:
Journal of gastrointestinal cancer. 50(2)
We aimed to evaluate the efficacy and outcomes of radioembolization with Yttrium-90 (Y-90) microspheres in patients with unresectable and chemorefractory colorectal cancer liver metastasis (CRCLM).This single-center study included 43 patients (34 mal